Last update 08 May 2025
Cellorigin Biotechnology (Hangzhou) Co., Ltd.

Cellorigin Biotechnology (Hangzhou) Co., Ltd.

Holding Company|2018|Zhejiang Sheng, China|
50-100
|

Overview

Basic Info

Introduction
CellOrigin Technology (Hangzhou) Co., Ltd. is dedicated to the advancement and clinical adaptation of engineered iPSCs for the production of innate immune cells such as CAR-iMac and CAR-iNK cells. By leveraging single-cell sequencing and gene regulatory network analysis, the company innovates from a developmental biology standpoint to enhance the differentiation process of iPSCs. With the application of CRISPR genome editing and synthetic biology techniques, CellOrigin has successfully developed engineered immune cells derived from iPSCs. Their portfolio includes several key patents that have received authorization both domestically and internationally.

Tags

Neoplasms
Endocrinology and Metabolic Disease
Hemic and Lymphatic Diseases
CAR-M
Natural Killer Cell Therapies
CAR-NK

Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
no Data
No Data
Top 5 Drug TypeCount
CAR-M5
Natural Killer Cell Therapies1
CAR-NK1
Monoclonal antibody1

Corporation Tree

Boost your research with our corporation tree data.
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 10 Jun 2025

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Discovery
5
1
Preclinical
Phase 1 Clinical
1
9
Other
Login to view more data

Current Projects

Drug(Targets)IndicationsGlobal Highest Phase
SY-001(CellOrigin)
Solid tumor
More
Phase 1
SY-005(CellOrigin)
Solid tumor
More
Preclinical
CO-007
Solid tumor
More
Discovery
CO-0066
Solid tumor
More
Discovery
CO-004
Solid tumor
More
Discovery
Login to view more data

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
Unearth financing trends to validate and advance investment opportunities.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free